Which is why, in part, the promise — and boom — of blood biomarkers testing has moved quickly in the past three to five years, researchers say. The FDA recently cleared two blood tests that detect ...
The blood test also had a sensitivity and specificity of 92.3% and 92.6% for participants who do not have breast cancer. The results were consistent for women with dense breast tissue and non-dense ...
SAN FRANCISCO -- A new commercially available test called T-Detect has received emergency use authorization from the FDA. The manufacturer says it has the power to tell most patients whether or not ...
New findings suggest blood tests still being assessed are showing promising results for early cancer screenings, especially ...
The next breakthrough in cancer screening is emerging from the convergence of artificial intelligence and canine biology. That’s the thesis behind SpotitEarly, a startup that recently launched in the ...
Recent study finds that 1 in 3 Norwegians over 70 have brain changes associated with Alzheimer's - Anadolu Ajansı ...
Oncodetect uses whole exome sequencing to analyze circulating tumor DNA, providing quantitative insights into disease status for informed treatment decisions. The test offers a "Detected" or "Not ...
Medical Device Network on MSN
MARAbio introduces MAR-Autism Test to detect maternal autoantibodies
MARAbio Systems has commercially introduced a new blood test for identifying maternal autoantibody related autism.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback